Skip to main content

Table 1 Antibodies recognizing CCR5 domains and their biologic properties

From: Natural anti-CCR5 antibodies in HIV-infection and -exposure

Table 1. Biological properties of some monoclonal and natural antibodies to CCR5; modified from [36].

Antibody

Source

Binding domain

Epitope(s)

Biologic properties

References

2D7

mAb

ECL2

Q170, K171, E172, W190

Inhibition of chemokine binding

Inhibition of cell activation (no Ca++ flux)

R5-HIV blocking

[27]

PA9

mAb

N-term ECL2

D2, Y3, Q4, S7, P8, N13

Y176, T177

Inhibition of chemokine binding

[27]

PA14

PRO140

mAb

hu mAb

N-term ECL2

D2

R168, Y176

Inhibition of chemokine binding

Inhibition of cell activation (no Ca++ flux)

R5-HIV blocking

[27]

[35, 56]

HGS004 (HGS101)

hu mAb

ECL2

Not available

Inhibition of chemokine binding without signaling HIV blocking

[57]

MC-1

mAb

ECL2

Not available

Inhibition of CCL4/MIP-1beta and CCL5/RANTES binding

CCR5 dimerization

CCR5 internalization

Inhibition of R5-HIV binding

[26]

MC-4

mAb

ECL2

Not available

CCL5/RANTES-mediated signaling

Inhibition of CCR5 endocytosis

[26]

MC-6

mAb

Multi-domain

conformational, multi-domain epitope

including K171, E172

CCL5/RANTES signaling without CCR5 internalization

[26]

RoAb12

RoAb14

RoAb18

mAb

ECL2

K171, E172, W190

Inhibition of CCR5-mediated cell fusion

Inhibition of CCL3/MIP-1alpha, CCL4/MIP-1beta, CCL5/RANTES binding

Inhibition of cell activation (no Ca++ flux)

Block of R5-HIV strains

[38, 40]

Natural anti-CCR5

Abs

Healthy donors Delta32+/+

CCR5- ESNHIV-positive

ECL2 N-term

Unknown within R168-K197 sequence

Competition for chemokine binding

Binding to native CCR5 on PBMC

Block of R5-HIV laboratory and primary isolates

[1, 15, 16, 21]

Natur alanti-CCR5

Abs

ESN

LTNP

ECL1

D95, F96 A95, A96 (gain of function)

A89, A103 (loss of function)

Inhibition of CCL4/MIP-1beta chemotaxis

Binding to native CCR5 on PBMC

CCR5 downregulation

Block of HIV transcytosis across membranes

Block of R5-HIV isolates from A, B, C, E clades

[22, 29, 30, 33, 81]